Molecular Diagnostics Markets

TriMark Publications
November 1, 2013
403 Pages - SKU: TRI5152052
Molecular Diagnostics Markets

  enlarge


Molecular Diagnostics Markets

The technologies that constitute molecular diagnostics--like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels--are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments. This TriMark Publications report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. It examines the prevalent clinical-measurement devices, as well as their reagents and supplies as utilized in hospitals, clinics, large reference laboratories and doctor’s offices. Diagnostic tests marketed primarily as over-the-counter are generally not included in this report, although there is inevitably some overlap. The main objectives of this analysis are: 1) identifying viable technology drivers through a comprehensive look at platform technologies for molecular diagnostics, including probe-based nucleic acid assays, microarrays and sequencing; 2) obtaining a complete understanding of the chief molecular diagnostics tests--i.e., predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic--from their basic principles to their applications; 3) discovering feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas and by focusing on expanding markets, such as communicable diseases, cardiology and oncology; and 4) focusing on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including growth forecasts.



More Molecular Diagnostics reports by TriMark Publications

Companion Diagnostics in Personalized Medicine and Cancer Therapy by TriMark Publications
Companion Diagnostics in Personalized Medicine and Cancer Therapy Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and ...
Molecular Diagnostics in Cancer Testing by TriMark Publications
Molecular Diagnostics in Cancer Testing Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies ...
Molecular Diagnostics in Infectious Disease Testing by TriMark Publications
Molecular Diagnostics in Infectious Disease Testing This TriMark Publications report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing ...
Molecular Diagnostics in Genetic Testing by TriMark Publications
Molecular Diagnostics in Genetic Testing Molecular diagnostics in genetic testing brings advanced analytical techniques to the diagnosis and treatment of genetic disorders. The confluence ...
See all reports like this >>

 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 3,400  
    Departmental Site License (one location, up to 10 users)  USD 6,800  
    Global Site License Fulfilled by Publisher  USD 10,200  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!